Literature DB >> 17131222

Lateral flexion in Parkinson's disease and Pisa syndrome.

Fusako Yokochi1.   

Abstract

Various types of abnormal posture are observed in Parkinson's disease (PD). Lateral flexion is very common and frequent among them. The clinical characteristics of lateral flexion in PD vary and are classified into two types, the chronic and subchronic types. The chronic type of lateral flexion in PD appears subclinically and worsens, which is related to the laterality of parkinsonian symptoms and the progression of the disease. The subchronic type of lateral flexion in PD develops subacutely and worsens rapidly in several months. An atypical and rare type of tonic truncal dystonia, Pisa syndrome, may be induced following the intake of neuroleptics. The clinical features of the subchronic type of lateral flexion in PD are similar to those of Pisa syndrome. Differences between lateral flexion in PD and Pisa syndrome are described.

Entities:  

Mesh:

Year:  2006        PMID: 17131222     DOI: 10.1007/s00415-006-7005-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  13 in total

1.  Effectiveness of anticholinergics and neuroleptic dose reduction on neuroleptic-induced pleurothotonus (the Pisa syndrome)

Authors:  T Suzuki; T Hori; A Baba; S Abe; H Shiraishi; T Moroji; J E Piletz
Journal:  J Clin Psychopharmacol       Date:  1999-06       Impact factor: 3.153

2.  JUDGMENT OF VISUAL AND POSTURAL VERTICAL BY PARKINSONIAN PATIENTS.

Authors:  F PROCTOR; M RIKLAN; I S COOPER; H L TEUBER
Journal:  Neurology       Date:  1964-04       Impact factor: 9.910

3.  Disruption of estimation of body-scaled aperture width in Hemiparkinson's disease.

Authors:  A C Lee; J P Harris; E A Atkinson; M S Fowler
Journal:  Neuropsychologia       Date:  2001       Impact factor: 3.139

4.  Pisa syndrome without neuroleptic exposure in a patient with Parkinson's disease: case report.

Authors:  Mattia Gambarin; Angelo Antonini; Giuseppe Moretto; Paolo Bovi; Silvia Romito; Antonio Fiaschi; Michele Tinazzi
Journal:  Mov Disord       Date:  2006-02       Impact factor: 10.338

5.  Reversible Pisa syndrome in Parkinson's disease during treatment with pergolide: a case report.

Authors:  Antonino Cannas; Paolo Solla; Gianluca Floris; Giuseppe Borghero; Paolo Tacconi; Andrea Spissu
Journal:  Clin Neuropharmacol       Date:  2005 Sep-Oct       Impact factor: 1.592

Review 6.  Drug-induced Pisa syndrome (pleurothotonus): epidemiology and management.

Authors:  Toshihito Suzuki; Hisashi Matsuzaka
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

7.  New dystonic syndrome associated with butyrophenone therapy.

Authors:  K Ekbom; H Lindholm; L Ljungberg
Journal:  Z Neurol       Date:  1972

8.  Scoliosis and Parkinson's disease.

Authors:  C D Marsden; R Duvoisin
Journal:  Arch Neurol       Date:  1980-04

9.  Pisa syndrome (pleurothotonus): report of a multicenter drug safety surveillance project.

Authors:  S Stübner; F Padberg; R Grohmann; H Hampel; M Hollweg; H Hippius; H J Möller; E Rüther
Journal:  J Clin Psychiatry       Date:  2000-08       Impact factor: 4.384

10.  Scoliosis in rats with experimentally-induced hemiparkinsonism: dependence upon striatal dopamine denervation.

Authors:  M Herrera-Marschitz; H Utsumi; U Ungerstedt
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-01       Impact factor: 10.154

View more
  14 in total

1.  Clinical heterogeneity and underlying pathophysiological mechanisms of lateral flexion of the trunk in Parkinson's disease.

Authors:  Eduardo de Pablo-Fernández; Alberto Villarejo-Galende
Journal:  J Neurol       Date:  2011-09-28       Impact factor: 4.849

2.  Lateral trunk flexion in Parkinson's disease: EMG features disclose two different underlying pathophysiological mechanisms.

Authors:  Alessandro Di Matteo; Alfonso Fasano; Giovanna Squintani; Lucia Ricciardi; Tommaso Bovi; Antonio Fiaschi; Paolo Barone; Michele Tinazzi
Journal:  J Neurol       Date:  2010-11-16       Impact factor: 4.849

3.  Lateral trunk flexion and Pisa syndrome in Parkinson's disease. Are they really always different conditions although denoting similar features?

Authors:  Paolo Solla; Antonino Cannas; Paolo Tacconi; Maria Giovanna Marrosu
Journal:  J Neurol       Date:  2008-02-26       Impact factor: 4.849

4.  Botulinum toxin type A and a rehabilitation program in the treatment of Pisa syndrome in Parkinson's disease.

Authors:  Andrea Santamato; Maurizio Ranieri; Francesco Panza; Stefano Zoccolella; Vincenza Frisardi; Vincenzo Solfrizzi; Maria Teresa Amoruso; Loredana Amoruso; Pietro Fiore
Journal:  J Neurol       Date:  2010-01       Impact factor: 4.849

5.  Pisa syndrome as presenting symptom of amyotrophic lateral sclerosis.

Authors:  Marcello Deriu; Daniela Murgia; Alessandra Paribello; Emanuele Marcia; Maurizio Melis; Giovanni Cossu
Journal:  J Neurol       Date:  2011-04-23       Impact factor: 4.849

6.  A clinical study of the coronal plane deformity in Parkinson disease.

Authors:  Xiaoyun Ye; Danning Lou; Xueping Ding; Chaoyan Xie; Jixiang Gao; Yuting Lou; Zhidong Cen; Yuxiang Xiao; Qianzhuang Miao; Fei Xie; Xiaosheng Zheng; Jianxin Wu; Fangcai Li; Wei Luo
Journal:  Eur Spine J       Date:  2017-03-09       Impact factor: 3.134

7.  Etiology and Management of Spinal Deformity in Patients With Parkinson's Disease.

Authors:  Roy Ruttiman; Adam E M Eltorai; Alan H Daniels
Journal:  Int J Spine Surg       Date:  2018-03-30

Review 8.  Therapy-resistant symptoms in Parkinson's disease.

Authors:  Ruxandra Julia Vorovenci; Roberta Biundo; Angelo Antonini
Journal:  J Neural Transm (Vienna)       Date:  2015-09-26       Impact factor: 3.575

9.  Reversible Pisa syndrome in patients with Parkinson's disease on dopaminergic therapy.

Authors:  Antonino Cannas; Paolo Solla; Gianluca Floris; Paolo Tacconi; Alessandra Serra; Mario Piga; Francesco Marrosu; Maria Giovanna Marrosu
Journal:  J Neurol       Date:  2009-03-18       Impact factor: 4.849

10.  Pisa syndrome in Parkinson's disease: an electrophysiological and imaging study.

Authors:  Michele Tinazzi; Ina Juergenson; Giovanna Squintani; Gaetano Vattemi; Stefania Montemezzi; Daniela Censi; Paolo Barone; Tommaso Bovi; Alfonso Fasano
Journal:  J Neurol       Date:  2013-05-22       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.